SEP 27, 2015 09:01 PM PDT

Role for Amyloid-Forming Protein

Learning how cells break down amyloids could help scientists to develop new drugs for Alzheimer's, as well as Parkinson's, Huntington's and rheumatoid arthritis.Amyloids, fibrous protein clumps often associated with diseases such as Alzheimer’s disease, form characteristic plaques in the brain. Learning how cells break down amyloids could help scientists to develop new drugs for Alzheimer’s, as well as Parkinson’s, Huntington’s and rheumatoid arthritis.
 
First described about 150 years ago, amyloids have since been tagged as key players in the above disease, but recent findings suggest that they may also have critical biological functions in healthy cells. A study appearing in Cell and reported in Bioscience Technology explains that MIT biologists have discovered that yeast cells need to build amyloid-like structures during the production of reproductive cells called spores. Finding out how yeast cells build and then break down these protein structures could lead to developing drugs that destroy disease-causing amyloids.
 
According to Luke Berchowitz, a postdoc at MIT’s Koch Institute for Integrative Cancer Research, and the paper’s lead author, “Amyloids in the brain persist for decades. We just can’t get rid of them, yet yeast cells seem to have a mechanism for getting rid of them in 15 minutes. If we can harness that mechanism, and really understand it, that could lead to anti-amyloid therapeutic opportunities.”
 
The researchers discovered the yeast amyloid-forming protein known as Rim4 while investigating how sexual reproduction works in yeast. Rim4 contains long regions of disorder and stretches rich in the amino acid asparagine, a hallmark of a type of amyloid-forming proteins known as prions. They had previously discovered that Rim4 latches onto messenger RNA (mRNA) molecules, which carry genetic information to the cell’s protein-building machinery. Now they have found that Rim4 uses amyloid-like clusters to prevent these mRNA molecules from being transcribed into proteins. This process regulates the formation of spores, reproductive cells that are analogous to eggs and sperm.
 
While yeast cells normally reproduce asexually, they can also undergo sexual reproduction through creation of spores that fuse to form new cells. The MIT researchers discovered that as yeast cells near completion of sexual reproduction, Rim4 amyloid-like clusters are broken down, releasing mRNA required for the cells to complete meiosis, the type of cell division that produces spores.
 
The MIT researchers also discovered preliminary data suggesting that an amyloid protein known as DAZL plays the same role in sperm formation in mice. They believe that similar proteins are probably found in every organism that reproduces sexually, including humans. While it is still unclear why cells rely on amyloid-forming proteins for this type of regulation, amyloids have the ability to withstand the harsh environments in which sexual reproduction cells are formed.
 
Berchowitz concluded, “Amyloids are stable and they’re able to sequester things. They’re very tough guardians. It’s a great opportunity to study assembly, regulation, and function of amyloids in living cells. It’s pretty exciting that we can form them rapidly, synchronously and abundantly.”
 
About the Author
  • Ilene Schneider is the owner of Schneider the Writer, a firm that provides communications for health care, high technology and service enterprises. Her specialties include public relations, media relations, advertising, journalistic writing, editing, grant writing and corporate creativity consulting services. Prior to starting her own business in 1985, Ilene was editor of the Cleveland edition of TV Guide, associate editor of School Product News (Penton Publishing) and senior public relations representative at Beckman Instruments, Inc. She was profiled in a book, How to Open and Operate a Home-Based Writing Business and listed in Who's Who of American Women, Who's Who in Advertising and Who's Who in Media and Communications. She was the recipient of the Women in Communications, Inc. Clarion Award in advertising. A graduate of the University of Pennsylvania, Ilene and her family have lived in Irvine, California, since 1978.
You May Also Like
SEP 04, 2018
Drug Discovery
SEP 04, 2018
Dopamine Provided Targeted Therapy for Neuropsychiatric Disorders
According to a study published in Molecular Psychiatry, research scientists at Columbia University Vagelos College of Physicians and Surgeons have brought ...
OCT 01, 2018
Neuroscience
OCT 01, 2018
What is Lewy Body Dementia?
Dementia is a scary diagnosis, but what many people don't realize is that dementia is a general term that can refer to age-related cognitive decline or...
OCT 03, 2018
Videos
OCT 03, 2018
Understanding Brain Aneurysms
A brain aneurysm is a medical emergency, but many patients don’t understand much about them. First, it’s not the same a clot. An aneurysm is wh...
OCT 18, 2018
Cell & Molecular Biology
OCT 18, 2018
An Unexpected Role for Astrocytes
The brain starts out as a dynamic organ that is capable of many changes. That flexibility allows us to learn, adapt and grow....
NOV 14, 2018
Cell & Molecular Biology
NOV 14, 2018
Understanding Left-Right Dominance in the Brain
There are many common misconceptions about science, one of which is the belief that someone can be called right- or left-brained....
NOV 15, 2018
Drug Discovery
NOV 15, 2018
A Subclass of Anti-Aging Compounds Serves as Alzheimer's Drug Candidates
In a publication in Trends in Pharmacological Sciences, a subclass of anti-aging compounds, called geroneuroprotectors (GNPs), have been identified in rese...
Loading Comments...